Category: MedtronicSyndicate content

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pushing the envelope

October 24, 2014 by Brian Johnson

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pushing the envelope

U.S. Patent Office denies Medtronic request in Endotach stent case

October 22, 2014 by Val Kennedy

The U.S. Patent & Trademark Office denies Medtronic's request for inter partes review of a disputed patent in its ongoing case against Endotach.

U.S. Patent Office denies Medtronic request in Endotach stent case

U.S. government probes medical devices for possible cyber flaws

October 22, 2014 by MassDevice

The U.S. Homeland Security Dept. is investigating reports of cybersecurity flaws in medical devices including some made by Medtronic, St. Jude Medical and Hospira.

YYmeta

(Reuters) - The U.S. Homeland Security Dept. is investigating about 2 dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment that officials fear could be exploited by hackers, a senior official at the agency told Reuters.

Covidien, Medtronic shares jump on affirmation of $43B merger

October 22, 2014 by Brad Perriello

Shares of Medtronic and Covidien gain after Medtronic affirms its $43 billion acquisition plans, saying it now expects to close the deal for Covidien late this year or early in 2015.

Covidien, Medtronic shares jump on affirmation of $43B merger

JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A

October 22, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit

JNJ continues to pay hefty integration charges on Synthes deal

October 16, 2014 by Brian Johnson

FDA reverses stance on reporting requirement | Regulatory news for the week of October 20, 2014

October 21, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA yanks enhancement reporting requirement; FDA approves Medtronic's full-body MRI-safe lead; FDA strikes out again in Prevor drug-or-device case; Abbott inks co-distribution deal with Carl Zeiss Meditec; Boston Scientific wins CE Mark for Accolade MRI-safe pacemakers

FDA yanks enhancement reporting requirement

October 15, 2014 by Brad Perriello

Medtronic's new line of spinal implants drops

October 20, 2014 by Brad Perriello

A new line of spinal implants from Medtronic makes its debut on the global stage.

Medtronic's new line of spinal implants drops worldwide

Medtronic (NYSE:MDT) said it's introduced a new line of spinal implants made of a titanium-plastic combination for interbody fusion procedures.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp